METHODS FOR REDUCING BINGE OR COMPULSIVE EATING Russian patent published in 2017 - IPC A61K31/135 A61K31/485 A61P25/30 

FIELD: medicine.

SUBSTANCE: patient suffering from overweight or obesity is identified, and an effective combination of bupropion and naltrexone or pharmaceutically acceptable salts thereof are administered to the said patient. In particular, with a body mass index greater than or equal to 25 kg/m². At that, a therapeutically effective amount of naltrexone or salt thereof may be 4-50 mg per day, while bupropion, or a salt thereof - 30-500 mg per day.

EFFECT: reduced number of cases of binge or compulsive eating, reduced severity of cases of psychogenic or binge eating.

34 cl, 2 tbl, 6 ex